药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mecasermin
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Brentuximab vedotin.
Mecasermin
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Brentuximab vedotin.
Exenatide
Inebilizumab
The risk or severity of infection can be increased when Fingolimod is combined with Inebilizumab.
Exenatide
Adenovirus type 7 vaccine live
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Adenovirus type 7 vaccine live.
Exenatide
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Vibrio cholerae CVD 103-HgR strain live antigen.
Exenatide
Human adenovirus e serotype 4 strain cl-68578 antigen
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Human adenovirus e serotype 4 strain cl-68578 antigen.
Exenatide
BCG vaccine
The therapeutic efficacy of Fingolimod can be decreased when used in combination with BCG vaccine.
Exenatide
Bacillus calmette-guerin substrain danish 1331 live antigen
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Bacillus calmette-guerin substrain danish 1331 live antigen.
Exenatide
Typhoid Vaccine Live
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Typhoid Vaccine Live.
Exenatide
Anthrax vaccine
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Anthrax vaccine.
Exenatide
Yellow Fever Vaccine
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Yellow Fever Vaccine.
Exenatide
Bacillus calmette-guerin substrain connaught live antigen
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Bacillus calmette-guerin substrain connaught live antigen.
Exenatide
Bacillus calmette-guerin substrain tice live antigen
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Bacillus calmette-guerin substrain tice live antigen.
Exenatide
Rubella virus vaccine
The therapeutic efficacy of Fingolimod can be decreased when used in combination with Rubella virus vaccine.
Exenatide
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Fingolimod.
Exenatide
Lasmiditan
Lasmiditan may increase the bradycardic activities of Fingolimod.
Exenatide
Lefamulin
Lefamulin may increase the QTc-prolonging activities of Fingolimod.
Exenatide
Pitolisant
Fingolimod may increase the QTc-prolonging activities of Pitolisant.
Exenatide
Entrectinib
The risk or severity of QTc prolongation can be increased when Fingolimod is combined with Entrectinib.
Exenatide
Propacetamol
Fingolimod may increase the hepatotoxic activities of Propacetamol.